Related Experiment Video
Updated: May 4, 2026
An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses
Published on: November 28, 2010
Ovarian cancer: designing effective vaccines and specific diagnostic tools
Jean Pierre Spinosa1, Darja Kanduc
1Department Biosciences, Biotechnologies & Biopharmaceutics, University of Bari, Bari, Italy.
Aim:
Notwithstanding a renewed interest in the application of immunotherapy as an alternative to chemotherapy and radiotherapy for the treatment of ovarian cancer (OC), and in spite of the available knowledge about ovarian tumor-associated-antigens, the search for a vaccine against OC remains a scientific and clinical challenge. Likewise, immunodiagnostics can detect only a late stage of the disease. Thus, the development of new therapeutic and diagnostic options is highly desirable.
Methods:
Based on the low-similarity hypothesis, which supports the concept that immunogenicity is preferentially associated to sequences with no/low-similarity to the host proteome, and using Protein Information Resource peptide match program, we searched the ovarian tumor antigen CA125 for amino acid sequences unique to CA125 and absent in the remaining human proteins.
Results & Conclusion:
We identified a set of 159 pentapeptides unique to CA125 that might be used to design specific and effective immunological tools for diagnosis and treatment of OC.
Insights
Researchers identified 159 unique CA125 protein fragments for developing ovarian cancer (OC) vaccines and diagnostics. This discovery offers new avenues for immunotherapy and early detection of OC.
Area of Science:
- Oncology
- Immunology
- Biochemistry
Background:
- Ovarian cancer (OC) treatment faces challenges with chemotherapy and radiotherapy.
- Current immunotherapies and immunodiagnostics for OC have limitations.
- Novel therapeutic and diagnostic strategies for OC are urgently needed.
Purpose of the Study:
- To identify unique amino acid sequences in the ovarian tumor antigen CA125.
- To leverage the low-similarity hypothesis for enhanced immunogenicity.
- To develop novel tools for OC diagnosis and treatment.
Main Methods:
- Utilized the Protein Information Resource peptide match program.
- Searched for amino acid sequences unique to CA125.
- Applied the low-similarity hypothesis to identify immunogenic peptides.
Main Results:
- Identified 159 unique pentapeptides within the CA125 antigen.
- These sequences exhibit low similarity to the host proteome.
- The identified peptides are potential candidates for immunogenic tools.
Conclusions:
- The 159 unique CA125 pentapeptides can inform the design of specific OC vaccines.
- These findings may lead to more effective diagnostic methods for early OC detection.
- This research paves the way for advanced immunotherapy and immunodiagnostics in ovarian cancer.
Related Concept Videos
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:27Tumor Immunotherapy